THE EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I), IGF-II AND DES(1-3)IGF-I, A POTENT IGF ANALOG, ON GROWTH-HORMONE AND IGF-BINDING PROTEIN SECRETION FROM CULTURED RAT ANTERIOR-PITUITARY-CELLS

被引:26
作者
SIMES, JM
WALLACE, JC
WALTON, PE
机构
[1] CSIRO, DIV HUMAN NUTR, POB 10041, GOUGER ST, ADELAIDE, SA 5000, AUSTRALIA
[2] UNIV ADELAIDE, DEPT BIOCHEM, ADELAIDE, SA 5000, AUSTRALIA
关键词
D O I
10.1677/joe.0.1300093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I, a potent IGF-I analogue, on the secretion of GH and IGF-binding protein (IGFBP) from cultured rat anterior pituitary cells were measured. IGF-I and des(1-3)IGF-I stimulated GH secretion at low concentrations (maximally effective at 1 and 0.1-mu-g/l respectively) and inhibited GH secretion at higher concentrations. The half-maximal inhibitory concentrations (IC50) were approximately 20-mu-g/l and 1-mu-g/l for IGF-I and des(1-3)IGF-I respectively. Thus des(1-3)IGF-I was more potent than IGF-I in these effects on GH secretion. We postulate that the increased potency of des(1-3)IGF-I in affecting GH secretion is due to decreased binding of this peptide by pituitary IGFBP compared with IGF-I. In contrast with IGF-I and des(1-3)IGF-I, IGF-II did not stimulate GH secretion at low concentrations, but did inhibit GH secretion from pituitary cells with an IC50 of approximately 20-mu-g/l. Several IGFBPs ranging in molecular mass from 22 000 to 52 000 were detected in medium conditioned by cultured anterior pituitary cells. When measured by Western-ligand blotting and competitive ligand-binding techniques, these IGFBPs exhibited decreased binding of des(1-3)IGF-I compared with IGF-I and IGF-II. The production of IGFBP by anterior pituitary cells was stimulated by the addition of IGFs to the culture medium.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 36 条
[1]   HUMAN GROWTH-HORMONE AND SOMATOMEDIN-C SUPPRESS THE SPONTANEOUS RELEASE OF GROWTH-HORMONE IN UNANESTHETIZED RATS [J].
ABE, H ;
MOLITCH, ME ;
VANWYK, JJ ;
UNDERWOOD, LE .
ENDOCRINOLOGY, 1983, 113 (04) :1319-1324
[2]   A KEY FUNCTIONAL-ROLE FOR THE INSULIN-LIKE GROWTH FACTOR-I N-TERMINAL PENTAPEPTIDE [J].
BAGLEY, CJ ;
MAY, BL ;
SZABO, L ;
MCNAMARA, PJ ;
ROSS, M ;
FRANCIS, GL ;
BALLARD, FJ ;
WALLACE, JC .
BIOCHEMICAL JOURNAL, 1989, 259 (03) :665-671
[3]  
BALLARD FJ, 1989, BIOCHEM SOC SYMP, V55, P91
[4]  
BALLARD FJ, 1990, 72ND ANN M END SOC A
[5]   ON THE NOMENCLATURE OF THE IGF BINDING-PROTEINS [J].
BALLARD, J ;
BAXTER, R ;
BINOUX, M ;
CLEMMONS, D ;
DROP, S ;
HALL, K ;
HINTZ, R ;
RECHLER, M ;
RUTANEN, E ;
SCHWANDER, J .
ACTA ENDOCRINOLOGICA, 1989, 121 (05) :751-752
[6]  
Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0
[7]   SOMATOMEDIN-C MEDIATES GROWTH-HORMONE NEGATIVE FEEDBACK BY EFFECTS ON BOTH THE HYPOTHALAMUS AND THE PITUITARY [J].
BERELOWITZ, M ;
SZABO, M ;
FROHMAN, LA ;
FIRESTONE, S ;
CHU, L ;
HINTZ, RL .
SCIENCE, 1981, 212 (4500) :1279-1281
[8]  
BINOUX M, 1983, INSULIN LIKE GROWTH, P571
[9]   ISOLATION AND CHARACTERIZATION OF VARIANT IGF-1 AS WELL AS IGF-2 FROM ADULT HUMAN-BRAIN [J].
CARLSSONSKWIRUT, C ;
JORNVALL, H ;
HOLMGREN, A ;
ANDERSSON, C ;
BERGMAN, T ;
LUNDQUIST, G ;
SJOGREN, B ;
SARA, VR .
FEBS LETTERS, 1986, 201 (01) :46-50
[10]   FACTORS CONTROLLING BLOOD-CONCENTRATION OF SOMATOMEDIN-C [J].
CLEMMONS, DR ;
VANWYK, JJ .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1984, 13 (01) :113-143